TrkC ligand-photodynamic therapy conjugate (Texas A&M University System)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameTrkC ligand-photodynamic therapy conjugate (Texas A&M University System)
Drug Alias NameIY-IY-PDT
ClassificationBiologics
Mechanisms of ActionNeurotrophic tyrosine kinase receptor type 3 inhibitors
TargetsNeurotrophic tyrosine kinase receptor type 3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTexas A&M University System
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTexas A&M University System
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A